Figure 6.
In vitro release profiles of Sorafenib (SRF) from SLN A8 loaded with 0.8% or 1.0% w/v, compared to free drug suspension 1%, w/v (mean ± SD, n = 3).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.